The formulation includes BPC-157, a 15amino acid pentadecapeptide derived from a protective peptide sequence identified in human gastric juice, and TB-500, a synthetic peptide derived from thymosin beta-4, a naturally occurring actin-regulating protein present in many mammalian tissues
(Hershman 2013) Two-year follow-up confirmed persistent and worsening CIPN in the LC group without recovery, suggesting long-term harm
The Lancet Diabetes & Endocrinology, 5(6), 355-366
Apply to body, face and neck each day and night subsequent to purifying for imperfection less light complexion
Common side effects include gastrointestinal symptoms, modest heart rate increase, and potential gallbladder complications
Side effects cluster in the first 72 hours after each weekly injection and in the first 2 to 4 weeks of every dose escalation